NL191508C - Farmaceutisch preparaat, dat tenminste één glycinamidederivaat bevat, alsmede glycinamide derivaat, dat geschikt is voor gebruik in een zodanig preparaat. - Google Patents

Farmaceutisch preparaat, dat tenminste één glycinamidederivaat bevat, alsmede glycinamide derivaat, dat geschikt is voor gebruik in een zodanig preparaat.

Info

Publication number
NL191508C
NL191508C NL8001721A NL8001721A NL191508C NL 191508 C NL191508 C NL 191508C NL 8001721 A NL8001721 A NL 8001721A NL 8001721 A NL8001721 A NL 8001721A NL 191508 C NL191508 C NL 191508C
Authority
NL
Netherlands
Prior art keywords
glycinamide derivative
preparation
glycinamide
pharmaceutical preparation
preparation containing
Prior art date
Application number
NL8001721A
Other languages
English (en)
Dutch (nl)
Other versions
NL191508B (nl
NL8001721A (nl
Original Assignee
Continental Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from LU81069A external-priority patent/LU81069A1/fr
Priority claimed from LU81068A external-priority patent/LU81068A1/fr
Application filed by Continental Pharma filed Critical Continental Pharma
Publication of NL8001721A publication Critical patent/NL8001721A/nl
Publication of NL191508B publication Critical patent/NL191508B/xx
Application granted granted Critical
Publication of NL191508C publication Critical patent/NL191508C/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL8001721A 1979-03-22 1980-03-24 Farmaceutisch preparaat, dat tenminste één glycinamidederivaat bevat, alsmede glycinamide derivaat, dat geschikt is voor gebruik in een zodanig preparaat. NL191508C (nl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
LU81069A LU81069A1 (fr) 1979-03-22 1979-03-22 Derive de glycinamide, preparation de ce derive, son utilisation ainsi que composition contenant ce derive
LU81068A LU81068A1 (fr) 1979-03-22 1979-03-22 Derives de la glycinamide, leur preparation et utilisation, ainsi que compositions contenant ces derives
LU81068 1979-03-22
LU81069 1979-03-22

Publications (3)

Publication Number Publication Date
NL8001721A NL8001721A (nl) 1980-09-24
NL191508B NL191508B (nl) 1995-04-18
NL191508C true NL191508C (nl) 1995-08-21

Family

ID=26640253

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8001721A NL191508C (nl) 1979-03-22 1980-03-24 Farmaceutisch preparaat, dat tenminste één glycinamidederivaat bevat, alsmede glycinamide derivaat, dat geschikt is voor gebruik in een zodanig preparaat.

Country Status (18)

Country Link
US (1) US4639468A (sh)
AT (1) AT381302B (sh)
AU (1) AU536499B2 (sh)
CA (1) CA1184567A (sh)
CH (1) CH645091A5 (sh)
DE (2) DE3010599A1 (sh)
DK (1) DK162714C (sh)
ES (1) ES490536A0 (sh)
FI (1) FI82033C (sh)
FR (1) FR2451913A1 (sh)
GB (1) GB2048852B (sh)
GR (1) GR68005B (sh)
IE (1) IE49751B1 (sh)
IL (1) IL59679A (sh)
NL (1) NL191508C (sh)
NO (1) NO157817C (sh)
PT (1) PT70992A (sh)
SE (1) SE453917B (sh)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2937698A1 (de) * 1979-09-18 1981-04-02 A. Nattermann & Cie GmbH, 5000 Köln N-propionylsarcosinanilide, deren herstellungsverfahren und arzneimittel auf deren basis
FI832935A (fi) * 1982-08-20 1984-02-21 Midit Derivat av w-aminosyror, deras framstaellning samt dessa derivat innehaollande blandningar
US4798687A (en) * 1987-02-06 1989-01-17 Pennwalt Corporation 2-Amino-N-[1,2-Diphenyl-1-(thifluoromethyl)ethyl]acetamide derivatives
US4904681A (en) * 1987-12-01 1990-02-27 G. D. Searle & Co. D-cycloserine and its prodrugs as cognitive enhancers
US4891058A (en) * 1988-07-18 1990-01-02 Ici Americas Inc. 1-alkyl-3-aryl imidazolidine-2,4-diones and herbicidal use
US5278191A (en) * 1988-08-31 1994-01-11 G. D. Searle & Co. Diphenylmethylaminoacetamide derivatives as anti-convulsants
US5288905A (en) * 1988-10-07 1994-02-22 G. D. Searle & Co. Glycyl urea derivatives as anti-convulsants
US4944796A (en) * 1988-11-14 1990-07-31 Ici Americas Inc. Certain 2-(disubstituted amino) acetanilide herbicides
DE3915755A1 (de) * 1989-05-13 1990-11-29 Bayer Ag Fungizide mittel sowie substituierte aminosaeureamid-derivate und deren herstellung
IL94466A (en) * 1989-05-25 1995-01-24 Erba Carlo Spa Pharmaceutical preparations containing the history of A-amino carboxamide N-phenylalkyl are converted into such new compounds and their preparation
US5075337A (en) * 1989-07-26 1991-12-24 G. D. Searle & Co. Alpha-deuterated 2-alkylaminoacetamide derivatives having reduced toxicity for treatment of CNS disorders
US5153226A (en) * 1989-08-31 1992-10-06 Warner-Lambert Company Acat inhibitors for treating hypocholesterolemia
DE4102042A1 (de) * 1991-01-24 1992-07-30 Bayer Ag Substituierte aminosaeureamid-derivate deren herstellung und verwendung als fungizide
US5141960A (en) * 1991-06-25 1992-08-25 G. D. Searle & Co. Tricyclic glycinamide derivatives as anti-convulsants
GB9306886D0 (en) * 1993-04-01 1993-05-26 Erba Carlo Spa Substituted (arylakoxybenzyl) aminopropanamide derivatives and process for their preparation
GB9306899D0 (en) * 1993-04-01 1993-05-26 Erba Carlo Spa Substituted (arylalkylaminobenzyl) aminopropionamide derivatives and process for their preparation
US5585358A (en) * 1993-07-06 1996-12-17 Yissum Research Development Corporation Of The Hebrew University Of Jerusalem Derivatives of valproic acid amides and 2-valproenoic acid amides, method of making and use thereof as anticonvulsant agents
WO1997045115A1 (en) * 1996-05-31 1997-12-04 Trophix Pharmaceuticals, Inc. Pharmaceutical for treatment of neurological and neuropsychiatric disorders
US6191165B1 (en) * 1996-05-31 2001-02-20 Allelix Neuroscience Inc. Pharmaceutical for treatment of neurological and neuropsychiatric disorders
IT1283489B1 (it) * 1996-07-23 1998-04-21 Chiesi Farma Spa Ammidi di alfa-amminoacidi,loro preparazione e loro impiego terapeutico
GB9727523D0 (en) 1997-12-31 1998-02-25 Pharmacia & Upjohn Spa Alpha-aminoamide derivatives useful as analgesic agents
CA2325943A1 (en) * 1998-03-26 1999-09-30 University Of Saskatchewan Technologies Inc. Aliphatic amino carboxylic and amino phosphonic acids, amino nitriles and amino tetrazoles as cellular rescue agents
US6984754B1 (en) 1998-03-26 2006-01-10 University Of Saskatchewan Technologies Inc. Aliphatic amino carboxylic and amino phosphonic acids amino nitriles and amino tetrazoles as cellular rescue agents
US6346547B1 (en) * 1999-02-08 2002-02-12 Checkpoint, Genetics, Inc. N-substituted amino acids, antioxidant pharmaceutical compositions containing n-substituted amino acids and methods for preventing cardiovascular diseases and/or preventing and/or treating antioxidant responsive diseases therewith
NZ523917A (en) * 2000-07-21 2004-11-26 Teva Pharma Use of derivatives of valproic acid and 2-valproenic acid amides for the treatment of mania in bipolar disorder
CA2418455A1 (en) * 2000-08-17 2002-02-21 Teva Pharmaceutical Industries, Ltd. Valproic acid derivatives for the treatment of pain
AU2002224847A1 (en) * 2000-11-21 2002-06-03 U C B, S.A. N-alkylated gaba compounds, processes for their preparation and their use as medicaments
EA006636B1 (ru) 2001-02-16 2006-02-24 Эллеликс Ньюросайенс, Инк. Замещенные амины (варианты), способ их получения и их применение в качестве ингибиторов транспорта глицина (варианты), композиция (варианты), промежуточный иодид и способ его получения, способ лечения пациента (варианты)
US20030035784A1 (en) * 2001-03-05 2003-02-20 Kao Corporation Hair cosmetic, aminocarboxylic acid amide and method for producing the same
EP1423168B1 (en) 2001-09-03 2006-02-08 Newron Pharmaceuticals S.p.A. Pharmaceutical composition comprising gabapentin or an analogue thereof and an alpha-aminoamide and its analgesic use
EP1438956A1 (en) * 2003-01-16 2004-07-21 Newron Pharmaceuticals S.p.A. Alpha-aminoamide derivatives useful as antimigraine agents
ES2347581T3 (es) * 2004-09-10 2010-11-02 Newron Pharmaceuticals S.P.A. Uso de (r)-(halobenciloxi)bencilamino-propanamidas como moduladores selectivos del canal de sodio y/o calcio.
CA2577321C (en) * 2004-09-13 2013-07-23 Jeffrey A. Levine Alkylaminoacetamide lubricant additives
FR2896991A1 (fr) * 2006-02-03 2007-08-10 Inst Nat Sante Rech Med Procede pour preparer un compose organique a l'etat solide et compositions pharmaceutiques comprenant ledit compose organique
CN102351733B (zh) * 2011-07-21 2014-03-19 凯莱英医药化学（阜新）技术有限公司 一种制备2-氨基-n,n-二甲基乙酰胺盐酸盐的方法
CA2953341C (en) 2014-06-25 2023-01-24 Acuitas Therapeutics Inc. Lipids and lipid nanoparticle formulations for delivery of nucleic acids
JP6053724B2 (ja) * 2014-06-26 2016-12-27 国立大学法人九州大学 イオン交換樹脂及び金属の吸着分離方法
US10221127B2 (en) 2015-06-29 2019-03-05 Acuitas Therapeutics, Inc. Lipids and lipid nanoparticle formulations for delivery of nucleic acids
RS63986B1 (sr) 2015-10-28 2023-03-31 Acuitas Therapeutics Inc Novi lipidi i lipidne formulacije nanočestica za isporuku nukleinskih kiselina
CN106187829B (zh) * 2016-07-29 2017-12-15 万华化学集团股份有限公司 一种制备乙二胺基乙磺酸盐的方法
US11357856B2 (en) 2017-04-13 2022-06-14 Acuitas Therapeutics, Inc. Lipids for delivery of active agents
JP7297676B2 (ja) 2017-04-28 2023-06-26 アクイタス セラピューティクス インコーポレイテッド 新規なカルボニル脂質、および核酸を送達するための脂質ナノ粒子製剤
JP7355731B2 (ja) 2017-08-16 2023-10-03 アクイタス セラピューティクス インコーポレイテッド 脂質ナノ粒子製剤における使用のための脂質
WO2019036028A1 (en) 2017-08-17 2019-02-21 Acuitas Therapeutics, Inc. LIPIDS FOR USE IN LIPID NANOPARTICULAR FORMULATIONS
WO2019036030A1 (en) 2017-08-17 2019-02-21 Acuitas Therapeutics, Inc. LIPIDS FOR USE IN LIPID NANOPARTICLE FORMULATIONS
CA3073018A1 (en) * 2017-08-17 2019-02-21 Acuitas Therapeutics, Inc. Lipids for use in lipid nanoparticle formulations
KR101953366B1 (ko) 2018-12-26 2019-02-28 정종문 침향을 포함하는 기억력 및 인지능력을 향상시키는 기능성 건강식품 및 이의 제조방법
CN113474328A (zh) 2019-01-11 2021-10-01 爱康泰生治疗公司 用于脂质纳米颗粒递送活性剂的脂质
USD926577S1 (en) 2019-09-23 2021-08-03 Verdant Ventures Tamper-resistant lid assembly
US11326923B2 (en) 2019-10-08 2022-05-10 Verdant Ventures Tamper-resistant lid assembly for dispensing a premeasured amount of liquid
US11976019B2 (en) 2020-07-16 2024-05-07 Acuitas Therapeutics, Inc. Cationic lipids for use in lipid nanoparticles

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2368208A (en) * 1940-12-16 1945-01-30 Emulsol Corp Chemical compounds and method of preparing same
US2781385A (en) * 1953-09-21 1957-02-12 Gefgy Chemical Corp Diamidocarboxylic acids and certain salts thereof
FI41563B (sh) * 1962-05-09 1969-09-01 Ferrosan Ab
JPS5319654B2 (sh) * 1974-03-14 1978-06-22
DE2832009A1 (de) * 1978-07-20 1980-01-31 Deutsches Krebsforsch Verwendung von sarkosin und sarkosinderivaten ls tumorhemmende wirksubstanzen

Also Published As

Publication number Publication date
ES8104790A1 (es) 1981-04-16
NL191508B (nl) 1995-04-18
DE3010599C2 (sh) 1989-03-02
DE3050800C2 (sh) 1989-06-22
ATA154680A (de) 1986-02-15
DK123580A (da) 1980-09-23
NO157817C (no) 1988-05-25
IE49751B1 (en) 1985-12-11
FI82033B (fi) 1990-09-28
FR2451913A1 (fr) 1980-10-17
NO800830L (no) 1980-09-23
IL59679A (en) 1984-11-30
GR68005B (sh) 1981-10-26
AU536499B2 (en) 1984-05-10
CH645091A5 (fr) 1984-09-14
US4639468A (en) 1987-01-27
DK162714B (da) 1991-12-02
SE453917B (sv) 1988-03-14
PT70992A (fr) 1980-04-01
FR2451913B1 (sh) 1984-07-13
FI82033C (fi) 1991-01-10
ES490536A0 (es) 1981-04-16
CA1184567A (en) 1985-03-26
IL59679A0 (en) 1980-06-30
AT381302B (de) 1986-09-25
FI800900A (fi) 1980-09-23
NL8001721A (nl) 1980-09-24
SE8002204L (sv) 1980-09-23
DK162714C (da) 1992-04-21
NO157817B (no) 1988-02-15
AU5678480A (en) 1980-09-25
DE3010599A1 (de) 1980-10-09
IE800599L (en) 1980-09-22
GB2048852A (en) 1980-12-17
GB2048852B (en) 1983-03-30

Similar Documents

Publication Publication Date Title
NL191508C (nl) Farmaceutisch preparaat, dat tenminste één glycinamidederivaat bevat, alsmede glycinamide derivaat, dat geschikt is voor gebruik in een zodanig preparaat.
NL191738B (nl) ML-236B-derivaten, werkwijze voor hun bereiding en farmaceutische preparaten, die deze derivaten bevatten.
NL7903421A (nl) N-gesubstitueerde moranolinederivaten, werkwijze voor de bereiding van een geneesmiddel daaruit en aldus verkregen geneesmiddel.
NL190552B (nl) 1-fenyl-4-alkyl-7,8-dialkoxy-5h-2,3-benzodiazepinederivaten en farmaceutische preparaten, die deze bevatten.
NL190237C (nl) Amino-ethers en geneesmiddel dat deze amino-ethers bevat.
NL182775B (nl) Corticosteroide bevattende farmaceutische preparaten.
GB2038812B (en) 1,2,4,5-tetra - alkyl - 4 - phenylpiperidines and pharmaceutical preparations thereof
DE2961804D1 (en) N-(3-benzoylpropyl)-spiro-(dihydrobenzofuranpiperidines and -pyrrolidines), derivatives thereof, methods for their preparation and their use for medicines
NL191307C (nl) Analgetisch werkzame piperazinederivaten en farmaceutische preparaten, die deze derivaten bevatten.
NL189041C (nl) Werkwijze ter bereiding van optisch aktieve azabicyclohexanen alsmede werkwijze ter bereiding van een farmaceutisch preparaat.
NL7802069A (nl) Pyrrolidinederivaten, werkwijze voor de berei- ding daarvan en dergelijke pyrrolidinederivaten bevattende geneesmiddelen.
NL187397C (nl) Farmaceutische preparaten, 20,21-dinoreburnamenineverbindingen daarvoor en werkwijze voor hun bereiding.
NL7903769A (nl) Di-o-n-alkylglycerolderivaten en farmaceutische preparaten daarvan.
ATE10094T1 (de) 3,4-bis-substituierte 1,2,5-oxadiazol-2-oxide, verfahren zu ihrer herstellung, und sie enthaltende pharmazeutische zubereitungen.
NL187239C (nl) N-gesubstitueerd 2-cyaanaziridinederivaat, werkwijze voor het bereiden daarvan en farmaceutisch preparaat dat een dergelijk preparaat bevat.
NL7802380A (nl) Benzylpyrimidinen, een werkwijze voor de berei- ding daarvan en farmaceutische preparaten die deze verbindingen bevatten.
ZA818968B (en) Thiaoline derivatives,processes for their preparation,their use and pharmaceutical preparations based on these compounds
NL7705561A (nl) Farmaceutisch preparaat en werkwijzen voor de bereiding en toepassing ervan.
DZ276A1 (fr) Préparations pharmaceutiques.
NL7902268A (nl) 2-hydroxymethylpyrazine-derivaten en een werkwijze voor de bereiding daarvan.
NL7714628A (nl) Gedisubstitueerde piperazinen, werkwijze voor de bereiding daarvan en dergelijke piperazinen bevattende geneesmiddelen.
NL190120C (nl) 2,3-dihydro-4h-1-benzopyran-4-on-0-carbamoyloximen alsmede farmaceutisch preparaat daarvan.
NL182641C (nl) 3-amino-5-(4-pyridyl)-1,2,4-triazoolderivaten en deze derivaten bevattende farmaceutische preparaten.
NL184896C (nl) Pyranochinolinonderivaten en gevormde farmaceutische preparaten die deze bevatten.
NL7714300A (nl) Werkwijze voor de bereiding van benzoylfenoxya- zijnzuurderivaten en de toepassing hiervan in een farmaceutisch preparaat.

Legal Events

Date Code Title Description
A1A A request for search or an international-type search has been filed
BB A search report has been drawn up
A85 Still pending on 85-01-01
CNR Transfer of rights (patent application after its laying open for public inspection)

Free format text: CONTINENTAL PHARMA, INC.

BC A request for examination has been filed
V4 Discontinued because of reaching the maximum lifetime of a patent

Free format text: 20000324